帕金森病药物反应的药物遗传学新见解。 - Suppr

Suppr

超能文献

Novel insights in pharmacogenetics of drug response in Parkinson's disease.

作者信息

Arbouw Maurits El, Guchelaar Henk-Jan, Egberts Toine Cg

出版信息

Pharmacogenomics. 2010 Feb;11(2):127-9. doi: 10.2217/pgs.09.175.

DOI:10.2217/pgs.09.175

PMID:20136351

Abstract

摘要

相似文献

Novel insights in pharmacogenetics of drug response in Parkinson's disease.

Pharmacogenomics. 2010 Feb;11(2):127-9. doi: 10.2217/pgs.09.175.

[Pharmacogenetics in Parkinson's disease treatment].

Neurol Neurochir Pol. 2008 Mar-Apr;42(2):131-8.

Parkinson's disease pharmacogenomics: new findings and perspectives.

Pharmacogenomics. 2014 Jun;15(9):1253-71. doi: 10.2217/pgs.14.93.

[Pathogenesis and basis of the therapy of Parkinson's disease].

Ned Tijdschr Geneeskd. 1981 Apr 18;125(16):620-5.

[Optimization of the treatment of Parkinson's disease using dopamine agonists].

Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):282-7.

The future of pharmacogenetics in Parkinson's disease treatment.

Pharmacogenomics. 2018 Feb;19(3):171-174. doi: 10.2217/pgs-2017-0180. Epub 2017 Dec 1.

[Parkinson's diseases: power of search].

Rev Neurol (Paris). 2010 Oct;166(10):755. doi: 10.1016/j.neurol.2010.07.011.

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

Pharmacogenomics. 2007 Feb;8(2):159-76. doi: 10.2217/14622416.8.2.159.

[Therapeutic strategies in Parkinson's disease].

Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):277-81.

Medications for Parkinson's disease.

Neurologist. 2007 Nov;13(6):387-8. doi: 10.1097/NRL.0b013e318158e47d.

引用本文的文献

Pharmacogenetics of Parkinson's Disease in Clinical Practice.

Mov Disord Clin Pract. 2016 Nov 1;4(2):173-180. doi: 10.1002/mdc3.12444. eCollection 2017 Mar-Apr.

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Eur J Clin Pharmacol. 2016 Nov;72(11):1335-1341. doi: 10.1007/s00228-016-2111-4. Epub 2016 Aug 6.

Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective.

Neurotherapeutics. 2014 Jan;11(1):111-6. doi: 10.1007/s13311-013-0237-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Novel insights in pharmacogenetics of drug response in Parkinson's disease.

Pharmacogenomics. 2010 Feb;11(2):127-9. doi: 10.2217/pgs.09.175.

[Pharmacogenetics in Parkinson's disease treatment].

Neurol Neurochir Pol. 2008 Mar-Apr;42(2):131-8.

Parkinson's disease pharmacogenomics: new findings and perspectives.

Pharmacogenomics. 2014 Jun;15(9):1253-71. doi: 10.2217/pgs.14.93.

[Pathogenesis and basis of the therapy of Parkinson's disease].

Ned Tijdschr Geneeskd. 1981 Apr 18;125(16):620-5.

[Optimization of the treatment of Parkinson's disease using dopamine agonists].

Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):282-7.

The future of pharmacogenetics in Parkinson's disease treatment.

Pharmacogenomics. 2018 Feb;19(3):171-174. doi: 10.2217/pgs-2017-0180. Epub 2017 Dec 1.

[Parkinson's diseases: power of search].

Rev Neurol (Paris). 2010 Oct;166(10):755. doi: 10.1016/j.neurol.2010.07.011.

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

Pharmacogenomics. 2007 Feb;8(2):159-76. doi: 10.2217/14622416.8.2.159.

[Therapeutic strategies in Parkinson's disease].

Arch Neurobiol (Madr). 1991 Nov-Dec;54(6):277-81.

Medications for Parkinson's disease.

Neurologist. 2007 Nov;13(6):387-8. doi: 10.1097/NRL.0b013e318158e47d.

引用本文的文献

Pharmacogenetics of Parkinson's Disease in Clinical Practice.

Mov Disord Clin Pract. 2016 Nov 1;4(2):173-180. doi: 10.1002/mdc3.12444. eCollection 2017 Mar-Apr.

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Eur J Clin Pharmacol. 2016 Nov;72(11):1335-1341. doi: 10.1007/s00228-016-2111-4. Epub 2016 Aug 6.

Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective.

Neurotherapeutics. 2014 Jan;11(1):111-6. doi: 10.1007/s13311-013-0237-y.